Not All Generics Are Created Equal: Study Exposes a 54% Higher Risk in Indian-Made Drugs
A new study reveals that generic drugs made in India are linked to a significantly higher number of severe adverse events, ...
Medicare Agency to End Some Demonstration Projects, Cancel $2 Generic Drug Initiative
The Centers for Medicare and Medicaid Services plans to terminate four demonstration projects by the end of 2025, closing out ...
Compounded Wegovy and Zepbound may disappear under new FDA rules
Patients turned to compound versions, which were made by licensed pharmacists but were not FDA approved. Last year, around ...
Key diabetes drug to cost up to 90% less in a few days
Indian drug companies are set to revolutionize diabetes treatment with affordable generic versions of Empagliflozin, ...
The Financial Express5d
Mankind to sell its diabetes drug, Empagliflozin, for Rs 5, company expects 50% volume growth: Rajeev Juneja
Glenmark and Alkem Labs launched the generic version as well as its Fixed Dose Combination (FDCs) of Empagliflozin in India.
Judge Certifies Bellwether Classes in Generic Drug Litigation
A federal judge certified several classes of direct and end-payer purchasers for test trials in drug price-fixing litigation against makers of two generic drugs, clomipramine and clobetasol.
Washington Square News6dOpinion
Off Topic: Patent abuse is to blame for the price of prescription drugs
Between 2005 and 2015, nearly three-fourths of issued drug patents were for already existing drugs. A common argument in ...
Hikma looks to launch generic versions of Novo Nordisk diabetes drugs, FT says
Hikma Pharmaceuticals (HKMPF) is in talks with partners across the world to prepare to sell a generic version of Ozempic and Wegovy, as patents ...
Rediff Money5d
Indian Generic Drugs Meet Global Standards: IPA
The Indian Pharmaceutical Alliance refutes a study claiming Indian generic drugs have higher adverse events, stating quality ...